247 related articles for article (PubMed ID: 10681651)
1. Molecular genetics of homocysteine metabolism.
Födinger M; Buchmayer H; Sunder-Plassmann G
Miner Electrolyte Metab; 1999; 25(4-6):269-78. PubMed ID: 10681651
[TBL] [Abstract][Full Text] [Related]
2. Homocysteine and ischaemic heart disease.
Law MR; Wald NJ
Haematologica; 1999 Jun; 84 Suppl EHA-4():57-60. PubMed ID: 10907469
[No Abstract] [Full Text] [Related]
3. Genetic defects as important factors for moderate hyperhomocysteinemia.
Geisel J; Zimbelmann I; Schorr H; Knapp JP; Bodis M; Hübner U; Herrmann W
Clin Chem Lab Med; 2001 Aug; 39(8):698-704. PubMed ID: 11592436
[TBL] [Abstract][Full Text] [Related]
4. Genetic and nutritional factors contributing to hyperhomocysteinemia in young adults.
Kluijtmans LA; Young IS; Boreham CA; Murray L; McMaster D; McNulty H; Strain JJ; McPartlin J; Scott JM; Whitehead AS
Blood; 2003 Apr; 101(7):2483-8. PubMed ID: 12642343
[TBL] [Abstract][Full Text] [Related]
5. Genetic causes of mild hyperhomocysteinemia in patients with premature occlusive coronary artery diseases.
Tsai MY; Welge BG; Hanson NQ; Bignell MK; Vessey J; Schwichtenberg K; Yang F; Bullemer FE; Rasmussen R; Graham KJ
Atherosclerosis; 1999 Mar; 143(1):163-70. PubMed ID: 10208491
[TBL] [Abstract][Full Text] [Related]
6. Genetic basis of hyperhomocysteinemia.
Medina MA; Amores-Sánchez MI
Mol Genet Metab; 2000 Nov; 71(3):478-80. PubMed ID: 11073715
[No Abstract] [Full Text] [Related]
7. Homocysteine, folate enzymes and neural tube defects.
Molloy AM; Weir DG; Scott JM
Haematologica; 1999 Jun; 84 Suppl EHA-4():53-6. PubMed ID: 10907468
[No Abstract] [Full Text] [Related]
8. [Hyperhomocysteinemia: an independent risk factor or a simple marker of vascular disease?. 1. Basic data].
Guilland JC; Favier A; Potier de Courcy G; Galan P; Hercberg S
Pathol Biol (Paris); 2003 Mar; 51(2):101-10. PubMed ID: 12801808
[TBL] [Abstract][Full Text] [Related]
9. Effects of polymorphisms of methionine synthase and methionine synthase reductase on total plasma homocysteine in the NHLBI Family Heart Study.
Jacques PF; Bostom AG; Selhub J; Rich S; Ellison RC; Eckfeldt JH; Gravel RA; Rozen R;
Atherosclerosis; 2003 Jan; 166(1):49-55. PubMed ID: 12482550
[TBL] [Abstract][Full Text] [Related]
10. Genetic basis of neural tube defects. II. Genes correlated with folate and methionine metabolism.
Gos M; Szpecht-Potocka A
J Appl Genet; 2002; 43(4):511-24. PubMed ID: 12441636
[TBL] [Abstract][Full Text] [Related]
11. [The role of homocysteine and methylenetetrahydrofolate reductase, methionine synthase, methionine synthase reductase polymorphisms in the development of cardiovascular diseases and hypertension].
Marosi K; Agota A; Végh V; Joó JG; Langmár Z; Kriszbacher I; Nagy ZB
Orv Hetil; 2012 Mar; 153(12):445-53. PubMed ID: 22411217
[TBL] [Abstract][Full Text] [Related]
12. Genetic modulation of homocysteinemia.
Rozen R
Semin Thromb Hemost; 2000; 26(3):255-61. PubMed ID: 11011843
[TBL] [Abstract][Full Text] [Related]
13. Methionine synthase (MTR) 2756 (A --> G) polymorphism, double heterozygosity methionine synthase 2756 AG/methionine synthase reductase (MTRR) 66 AG, and elevated homocysteinemia are three risk factors for having a child with Down syndrome.
Bosco P; Guéant-Rodriguez RM; Anello G; Barone C; Namour F; Caraci F; Romano A; Romano C; Guéant JL
Am J Med Genet A; 2003 Sep; 121A(3):219-24. PubMed ID: 12923861
[TBL] [Abstract][Full Text] [Related]
14. Polymorphisms of genes involved in homocysteine metabolism in preeclampsia and in uncomplicated pregnancies.
Also-Rallo E; Lopez-Quesada E; Urreizti R; Vilaseca MA; Lailla JM; Balcells S; Grinberg D
Eur J Obstet Gynecol Reprod Biol; 2005 May; 120(1):45-52. PubMed ID: 15866085
[TBL] [Abstract][Full Text] [Related]
15. Are genetic variants of the methyl group metabolism enzymes risk factors predisposing to obesity?
Terruzzi I; Senesi P; Fermo I; Lattuada G; Luzi L
J Endocrinol Invest; 2007 Oct; 30(9):747-53. PubMed ID: 17993766
[TBL] [Abstract][Full Text] [Related]
16. [Molecular genetics of the remethylation of homocysteine].
Chango A; Parrot-Roulaud F; Nicolas J
Ann Biol Clin (Paris); 1999; 57(1):37-42. PubMed ID: 9920965
[TBL] [Abstract][Full Text] [Related]
17. Transcobalamin and methionine synthase reductase mutated polymorphisms aggravate the risk of neural tube defects in humans.
Guéant-Rodriguez RM; Rendeli C; Namour B; Venuti L; Romano A; Anello G; Bosco P; Debard R; Gérard P; Viola M; Salvaggio E; Guéant JL
Neurosci Lett; 2003 Jul; 344(3):189-92. PubMed ID: 12812837
[TBL] [Abstract][Full Text] [Related]
18. [Genetic risk factors of neural tube defects].
Sliwerska E; Szpecht-Potocka A
Med Wieku Rozwoj; 2002; 6(4):349-70. PubMed ID: 12810987
[TBL] [Abstract][Full Text] [Related]
19. Accurate and rapid "multiplex heteroduplexing" method for genotyping key enzymes involved in folate/homocysteine metabolism.
Barbaux S; Kluijtmans LA; Whitehead AS
Clin Chem; 2000 Jul; 46(7):907-12. PubMed ID: 10894832
[TBL] [Abstract][Full Text] [Related]
20. Gene polymorphisms of homocysteine metabolism-related enzymes in Chinese patients with occlusive coronary artery or cerebral vascular diseases.
Zhang G; Dai C
Thromb Res; 2001 Nov; 104(3):187-95. PubMed ID: 11672761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
